Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial

Data published in New England Journal of Medicine and presented as a late breaking abstract in mini oral session at ESMO Congress 2023 KIMMTRAK demonstrated long-term survival benefit in HLA-A*02:01 positive patients with previously untreated metastatic uveal melanoma (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md, 21 October 2023) Immunocore Holdings plc (Nasdaq: IMCR), a […]

Read More

LambdaTest Launches New Auto-Heal Feature to Enhance Test Reliability

LambdaTest’s Auto-Heal aims to streamline software testing by automatically adapting tests to changes in applications, offering reliability, eliminating flaky tests, and reducing maintenance, providing a solution to common challenges in automated testing. San Francisco , Oct. 20, 2023 (GLOBE NEWSWIRE) — LambdaTest, a leading cloud-based unified testing platform introduced the Auto-heal feature, designed to streamline […]

Read More

Evergreen and CIP team up to explore green shipping fuels

Evergreen targets to achieve net-zero by 2050 in line with the International Maritime Organization’s GHC strategy. To do so, Evergreen has teamed up with the world’s largest fund manager within greenfield renewable energy, Copenhagen Infrastructure Partners for a collaboration on hydrogen-based marine fuels. TAIPEI, Taiwan and COPENHAGEN, Denmark, Oct. 20, 2023 (GLOBE NEWSWIRE) — Evergreen […]

Read More

Meltwater Winter Product Release delivers greater impact with faster time to value, better analytics and continuous rollout of generative AI capabilities

SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) — Meltwater, a leading global provider of social, media and consumer intelligence, today announces its Winter Release with new product enhancements that will help Meltwater customers be more efficient and effective through greater PR impact, better analytics and faster time to value. The use of AI-powered solutions continues […]

Read More

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Marburg Vaccine in Uganda

Clinical Trial Preparation WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus. Healthy volunteers received the single-dose vaccine at Makerere University Walter Reed Project (MUWRP) in Kampala, Uganda today. There are currently no vaccines or antiviral treatments […]

Read More

The Metals Company Provides Closing Update on its Registered Direct Offering at $2.00 Per Share Plus Class A Warrants

NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today provided an update to its previously announced registered direct offering (the “Registered Offering”), which is expected to result in aggregate gross proceeds to the Company […]

Read More